Pharming Group (PHAR)

• Market cap: $1.18B
• 1 day: -1.47%
• 5 days: 1.95%
• 1 month: 1.39%
• 3 months: -0.89%
• 6 months: 27.13%
• Year to date: -2.39%
• 1 year: 78.36%
• 5 years: 33.2%
• 10 years: 0.18%
• Sector: Healthcare
• Industry: Biotechnology

About: Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.

Employees: 409